Resource utilization and costs associated with chemotherapy-induced nausea and vomiting (CINV) following highly or moderately emetogenic chemotherapy administered in the US outpatient hospital setting

Supportive Care in Cancer

Volumn 19, Issue 1, 2011, Pages 131-140

  Burke, Thomas A ^a   Wisniewski, Tami ^a   Ernst, Frank R ^b  

^a MERCK RESEARCH LABORATORIES   (United States)

^b Premier Research Services   (United States)

Author keywords

Antiemetic therapy; Cancer; Chemotherapy; Costs; Emesis; Nausea; Vomiting

Indexed keywords

ANTHRACYCLINE; ANTIEMETIC AGENT; ANTIHISTAMINIC AGENT; BENZODIAZEPINE; BLEOMYCIN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; IRINOTECAN; NAVELBINE; NEUROKININ 1 RECEPTOR ANTAGONIST; OXALIPLATIN; PREDNISONE; SEROTONIN 3 ANTAGONIST; TAXANE DERIVATIVE; VINBLASTINE; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CHEMOTHERAPY INDUCED NAUSEA AND VOMITING; CONTROLLED STUDY; COST OF ILLNESS; EMERGENCY WARD; FEMALE; FOLLOW UP; HEALTH CARE UTILIZATION; HEALTH SERVICE; HOSPITAL COST; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA AND VOMITING; OUTPATIENT CARE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; UNITED STATES;

ADOLESCENT; ADULT; AGED; ANTIEMETICS; ANTINEOPLASTIC AGENTS; COHORT STUDIES; COST OF ILLNESS; DATABASES, FACTUAL; FEMALE; HEALTH CARE COSTS; HEALTH RESOURCES; HUMANS; MALE; MIDDLE AGED; NAUSEA; NEOPLASMS; OUTPATIENT CLINICS, HOSPITAL; RETROSPECTIVE STUDIES; UNITED STATES; VOMITING; YOUNG ADULT;

EID: 78651484683     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-009-0797-x     Document Type: Article

References (24)

1. MG Kris PJ Hesketh MR Somerfield P Feyer R Clark-Snow JM Koeller GR Morrow LW Chinnery MJ Chesney RJ Gralla SM Grunberg 2006 American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006 J Clin Oncol 24 2932 2947 1:CAS:528:DC%2BD28XntV2gs7k%3D 10.1200/JCO.2006.06.9591 16717289
2. National Comprehensive Cancer Network (2009) Clinical practice guidelines in oncology. Antiemesis. V.1. http://www.nccn.org/professionals/physician-gls/ PDF/antiemesis.pdf. Accessed 15 July 2009
3. Multinational Association of Supportive Care in Cancer (MASCC). Antiemetic guidelines. http://www.mascc.org/mc/page.do?sitePageId= 88041&orgId=mascc. Accessed 15 July 2009
4. A Ihbe-Heffinger B Ehlken R Bernard K Berger C Peschel HG Eichler R Deuson J Thodtmann F Lordick 2004 The impact of delayed chemotherapy-induced nausea and vomiting on patients, health resource utilization and costs in German cancer centers Ann Oncol 15 526 536 1:STN:280:DC%2BD2c7gvVertg%3D%3D 10.1093/annonc/mdh110 14998860
5. A Molassiotis MP Saunders J Valle G Wilson P Lorigan A Wardley E Levine R Cowan J Loncaster C Rittenberg 2008 A prospective observational study of chemotherapy-related nausea and vomiting in routine practice in a UK cancer centre Support Care Cancer 16 201 208 1:STN:280:DC%2BD1c%2FkslCjtA%3D%3D 10.1007/s00520-007-0343-7 17926070
6. A Glaus C Knipping R Morant C Bohme B Lebert F Beldermann B Glawogger PF Ortega A Husler R Deuson 2004 Chemotherapy-induced nausea and vomiting in routine practice: a European perspective Support Care Cancer 12 708 715 10.1007/s00520-004-0662-x 15278682
7. L Cohen CA de Moor P Eisenberg EE Ming H Hu 2007 Chemotherapy-induced nausea and vomiting: incidence and impact on patient quality of life at community oncology settings Support Care Cancer 15 497 503 10.1007/s00520-006- 0173-z 17103197
8. B Bloechl-Daum RR Deuson P Mavros M Hansen J Herrstedt 2006 Delayed nausea and vomiting continue to reduce patients' quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment J Clin Oncol 24 4472 4478 1:CAS:528:DC%2BD28XhtVyisrrL 10.1200/JCO.2006.05.6382 16983116
9. SM Grunberg RR Deuson P Mavros O Geling M Hansen G Cruciani B Daniele G De Pouvourville EB Rubenstein G Daugaard 2004 Incidence of chemotherapy-induced nausea and emesis after modern antiemetics Cancer 100 2261 2268 10.1002/cncr.20230 15139073
10. E Ballatori F Roila B Ruggeri M Betti S Sarti G Soru G Cruciani M Di Maio B Andrea RR Deuson 2007 The impact of chemotherapy-induced nausea and vomiting on health-related quality of life Support Care Cancer 15 179 185 10.1007/s00520-006-0109-7 16941136
11. GR Morrow JA Roscoe JT Hickok RM Stern HI Pierce DB King TK Banerjee P Weiden 1998 Initial control of chemotherapy-induced nausea and vomiting in patient quality of life Oncology (Williston Park) 12 32 37 1:STN:280: DyaK1c3hslGhtQ%3D%3D
12. MG Kris 2003 Why do we need another antiemetic? Just ask J Clin Oncol 21 4077 4080 1:CAS:528:DC%2BD2cXpsVajsbc%3D 10.1200/JCO.2003.07.968 14559888
13. CT Liau NM Chu HE Liu R Deuson J Lien JS Chen 2005 Incidence of chemotherapy-induced nausea and vomiting in Taiwan: physicians' and nurses' estimation vs. patients' reported outcomes Support Care Cancer 13 277 286 10.1007/s00520-005-0788-5 15770489
14. E Ballatori F Roila 2003 Impact of nausea and vomiting on quality of life in cancer patients during chemotherapy Health Qual Life Outcomes 1 46 10.1186/1477-7525-1-46 14521717
15. E Ballatori F Roila B Ruggeri S Porrozzi M Iannopollo G Soru G Cruciani B Daniele MC Locatelli J Pellissier R Deuson 2007 The cost of chemotherapy-induced nausea and vomiting in Italy Support Care Cancer 15 31 38 10.1007/s00520-006-0094-x 16788840
16. YC Tina Shih Y Xu LS Elting 2007 Costs of uncontrolled chemotherapy-induced nausea and vomiting among working-age cancer patients receiving highly or moderately emetogenic chemotherapy Cancer 110 678 685 10.1002/cncr.22823 17567835
17. Roila F, Hesketh PJ, Herrstedt J, Antiemetic Subcommittee of the Multinational Association of Supportive Care in Cancer 2006 Prevention of chemotherapy- and radiotherapy-induced emesis: results of the 2004 Perugia International Antiemetic Consensus Conference Ann Oncol 17 20 28 10.1093/annonc/mdj078
18. RD Mosteller 1987 Simplified calculation of body-surface area N Engl J Med 317 1098 1:STN:280:DyaL1c%2FhsVSmtw%3D%3D 3657876
19. Weiner MG, Livshits A, Carozzoni C, McMenamin E, Gibson G, Loren A, Hennessy S (2003) Derivation of malignacy status from ICD-9 codes. American Medical Informatics Association 2003 Symposium Proceedings: 1050
20. PJ Hesketh 2008 Chemotherapy-induced nausea and vomiting N Engl J Med 358 2482 2494 1:CAS:528:DC%2BD1cXmvFKltL0%3D 10.1056/NEJMra0706547 18525044
21. A Molassiotis P Fernadez-Ortega D Pud G Ozden JA Scott V Panteli A Margulies M Browall M Magri S Selvekerova E Madsen L Milovics I Bruyns G Gudmundsdottir S Hummerston AM Ahmad N Platin N Kearney E Patiraki 2005 Use of complementary and alternative medicine in cancer patients: a European survey Ann Oncol 16 655 663 1:STN:280:DC%2BD2M7kvVWnuw%3D%3D 10.1093/annonc/mdi110 15699021
22. J Lachaine L Yelle L Kaizer A Dufour S Hopkins R Deuson 2005 Chemotherapy-induced emesis: quality of life and economic impact in the context of current practice in Canada Support Cancer Ther 2 181 187 10.3816/SCT.2005.n. 011 18628170
23. DJ Stewart S Dahrouge D Coyle WK Evans 1999 Costs of treating and preventing nausea and vomiting in patients receiving chemotherapy J Clin Oncol 17 344 351 1:STN:280:DyaK1MzosFCgtw%3D%3D 10458253
24. S Moore J Tumeh S Wojtanowski C Flowers 2007 Cost-effectiveness of aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with highly emetogenic chemotherapy Value Health 10 23 31 10.1111/j.1524-4733.2006.00141.x 17261113